- Home
- PHIO vs HSCS Comparison
PHIO vs HSCS Comparison
Compare PHIO & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- HSCS
- Stock Information
- Founded
- PHIO 2011
- HSCS 2007
- Country
- PHIO United States
- HSCS United States
- Employees
- PHIO N/A
- HSCS N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- PHIO Health Care
- HSCS Health Care
- Exchange
- PHIO Nasdaq
- HSCS Nasdaq
- Market Cap
- PHIO 2.3M
- HSCS 2.7M
- IPO Year
- PHIO N/A
- HSCS 2022
- Fundamental
- Price
- PHIO $2.21
- HSCS $2.57
- Analyst Decision
- PHIO Strong Buy
- HSCS Strong Buy
- Analyst Count
- PHIO 1
- HSCS 1
- Target Price
- PHIO $36.00
- HSCS $15.00
- AVG Volume (30 Days)
- PHIO 41.4K
- HSCS 28.9K
- Earning Date
- PHIO 11-14-2024
- HSCS 12-12-2024
- Dividend Yield
- PHIO N/A
- HSCS N/A
- EPS Growth
- PHIO N/A
- HSCS N/A
- EPS
- PHIO N/A
- HSCS N/A
- Revenue
- PHIO N/A
- HSCS $18,600.00
- Revenue This Year
- PHIO N/A
- HSCS $8,948.39
- Revenue Next Year
- PHIO N/A
- HSCS $27.27
- P/E Ratio
- PHIO N/A
- HSCS N/A
- Revenue Growth
- PHIO N/A
- HSCS 853.85
- 52 Week Low
- PHIO $2.17
- HSCS $2.36
- 52 Week High
- PHIO $18.81
- HSCS $29.00
- Technical
- Relative Strength Index (RSI)
- PHIO 32.01
- HSCS 36.40
- Support Level
- PHIO $2.49
- HSCS $2.63
- Resistance Level
- PHIO $3.70
- HSCS $2.89
- Average True Range (ATR)
- PHIO 0.31
- HSCS 0.18
- MACD
- PHIO -0.10
- HSCS -0.01
- Stochastic Oscillator
- PHIO 2.75
- HSCS 0.69
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.